Using population estimates by the U.S. Census and rate of diabetes statistics from the Center for Disease Control (CDC), we’ve estimated the number of insulin users in each state and congressional district in the U.S.

Tracking political contributions from insulin manufacturers can expose politicians' potential bias towards the pharmaceutical industry.